BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 10206455)

  • 1. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
    Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
    J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
    Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil.
    Sandlund JT; Fonseca T; Leimig T; Verissimo L; Ribeiro R; Lira V; Berard CW; Sixbey J; Crist WM; Mao L; Chen G; Pui CH; Heim M; Pedrosa F
    Leukemia; 1997 May; 11(5):743-6. PubMed ID: 9180301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin's lymphomas in childhood. A clinicopathologic and epidemiologic study in Finland.
    Franssila KO; Heiskala MK; Rapola J
    Cancer; 1987 May; 59(10):1837-46. PubMed ID: 3493836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)].
    Wróbel G; Kazanowska B; Chybicka A; Jeleń M; Małdyk J; Sowińska E; Balcerska A; Balwierz W; Bubała H; Kołakowska-Mrozowska B; Kołtan A; Korzon M; Kowalczyk J; Krawczuk-Rybak M; Maciejka-Kapuścińska L; Matysiak M; Płoszyńska A; Popadiuk S; Solarz E; Sońta-Jakimczyk D; Sopyło B; Stańczak E; Stefaniak J; Stefańska K; Wachowiak J; Wieczorek M; Wysocki M
    Przegl Lek; 2004; 61 Suppl 2():45-8. PubMed ID: 15686045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A collaborative study of children with lymphoblastic non-Hodgkin's lymphoma in China].
    ;
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):931-7. PubMed ID: 26887549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92).
    Pillon M; Di Tullio MT; Garaventa A; Cesaro S; Putti MC; Favre C; Lippi A; Surico G; Di Cataldo A; D'Amore E; Zanesco L; Rosolen A
    Cancer; 2004 Jul; 101(2):385-94. PubMed ID: 15241838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood non-Hodgkin's lymphoma in the five Nordic countries. A five-year population-based study from the Nordic Society of Pediatric Hematology and Oncology.
    Márky I; Schmiegelow K; Perkkiö M; Jónsson OG; Storm-Mathiesen I; Gustafsson G; Kreuger A; Langmark F
    J Pediatr Hematol Oncol; 1995 May; 17(2):163-6. PubMed ID: 7749767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hungarian experience with non-Hodgkin's lymphoma in childhood].
    Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
    Magy Onkol; 2006; 50(3):253-9. PubMed ID: 17099787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
    Sposto R; Meadows AT; Chilcote RR; Steinherz PG; Kjeldsberg C; Kadin ME; Krailo MD; Termuhlen AM; Morse M; Siegel SE
    Med Pediatr Oncol; 2001 Nov; 37(5):432-41. PubMed ID: 11745871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
    d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
    J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
    Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Seidemann K; Tiemann M; Schrappe M; Yakisan E; Simonitsch I; Janka-Schaub G; Dörffel W; Zimmermann M; Mann G; Gadner H; Parwaresch R; Riehm H; Reiter A
    Blood; 2001 Jun; 97(12):3699-706. PubMed ID: 11389005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive Chemotherapy Without Radiotherapy Gives More than 85% Event-Free Survival for Non-Hodgkin Lymphoma Without Central Nervous Involvement: A 6-Year Population-Based Study From the Nordic Society of Pediatric Hematology and Oncology.
    Márky I; Björk O; Forestier E; Jónsson ÓG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-560. PubMed ID: 27811620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.